Trial Profile
Clinical Trials Insight: 700053578
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 Feb 2010
Price :
$35
*
At a glance
- Drugs Epratuzumab (Primary) ; Antineoplastics; Rituximab
- Indications Lymphoma
- Focus Therapeutic Use
- 15 Feb 2010 New trial record.